Latest news

Proscia and Nucleai partner to broaden access to AI predictive biomarkers

Nucleai and GoPath Diagnostics announce strategic collaboration

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment

Nucleai and Altis Labs are transforming clinical trials through AI innovation

Nucleai announces strategic collaboration with Mayo Clinic BioPharma Diagnostics

Nucleai and Adlai Nortye Partner to Identify and Validate Novel Spatial Biomarkers Across Adlai Clinical Trials

Nucleai closes $33 Million Series B financing to advance its spatial biology platform for drug research, Development and diagnostics

Nucleai and Jefferson Health Launch a Strategic Collaboration to discover novel Biomarkers

Nucleai Partners With Sheba Medical Center’s ARC Innovation Center For a New Strategic Data Collaboration